Title : Possible role of transforming growth factor-β1 and vascular endothelial growth factor in Fabry disease nephropathy.

Pub. Date : 2012 Dec

PMID : 23007467






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Fabry disease is a lysosomal storage disorder (LSD) caused by deficiency of alpha-galactosidase A (alpha-gal A), resulting in deposition of globotriaosylceramide (Gb3; also known as ceramide trihexoside) in the vascular endothelium of many organs. globotriaosylceramide galactosidase, alpha Mus musculus
2 Fabry disease is a lysosomal storage disorder (LSD) caused by deficiency of alpha-galactosidase A (alpha-gal A), resulting in deposition of globotriaosylceramide (Gb3; also known as ceramide trihexoside) in the vascular endothelium of many organs. globotriaosylceramide galactosidase, alpha Mus musculus
3 Fabry disease is a lysosomal storage disorder (LSD) caused by deficiency of alpha-galactosidase A (alpha-gal A), resulting in deposition of globotriaosylceramide (Gb3; also known as ceramide trihexoside) in the vascular endothelium of many organs. globotriaosylceramide galactosidase, alpha Mus musculus
4 Fabry disease is a lysosomal storage disorder (LSD) caused by deficiency of alpha-galactosidase A (alpha-gal A), resulting in deposition of globotriaosylceramide (Gb3; also known as ceramide trihexoside) in the vascular endothelium of many organs. globotriaosylceramide galactosidase, alpha Mus musculus